Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03603964
Title Guadecitabine Extension Study
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Astex Pharmaceuticals
Indications

acute myeloid leukemia

myelodysplastic syndrome

Advanced Solid Tumor

Therapies

Guadecitabine

Age Groups: adult | senior
Covered Countries USA | ITA | ESP | CAN | AUT


No variant requirements are available.